公司新闻 - 亚科因(Abbkine)—服务于细胞和蛋白研究全球用户
加入收藏 欢迎光临Abbkine Scientific Co., Ltd官方网站全国服务热线:400-6800-830
登录 注册
中文

亚科因(Abbkine)—服务于细胞和蛋白研究全球用户

货号 产品名称 文献标题 IF 杂志名称
KTD3001 蛋白质定量试剂盒(BCA法) Long noncoding RNA LINC01215 represses differentiation and proliferation of keratinocytes via zinc finger 652 in atopic dermatitis. 2 Journal of Radiation Research and Applied Sciences
KTD3001 蛋白质定量试剂盒(BCA法) Molecular docking and in vitro experiments verified that kaempferol induced apoptosis and inhibited human HepG2 cell proliferation by targeting BAX, CDK1, and … 4 Frontiers in Microbiology 
KTD3001 蛋白质定量试剂盒(BCA法) Engineered microparticles modulate arginine metabolism to repolarize tumor-associated macrophages for refractory colorectal cancer treatment. 6 Journal of Translational Medicine
KTD3001 蛋白质定量试剂盒(BCA法) Zhilining Formula alleviates DSS-induced colitis through suppressing inflammation and gut barrier dysfunction via the AHR/NF-κBp65 axis. 7 Phytomedicine
KTD3001 蛋白质定量试剂盒(BCA法) Lactate and H3K18 Lactylation Contribute To the Exacerbation of Acute Pancreatitis by Modulating NCOA4-mediated Ferroptosis Journal of Experimental & Clinical Cancer Research
KTD3001 蛋白质定量试剂盒(BCA法) 2D and 3D cultured human umbilical cord-derived mesenchymal stem cell-conditioned medium has a dual effect in type 1 diabetes model in rats … 7 Scientific Reports
KTD3001 蛋白质定量试剂盒(BCA法) Heat stress induces IL-1β and IL-18 overproduction via ROS-activated NLRP3 inflammasome: implication in neuroinflammation in mice with heat stroke. 2 Neuroreport
KTD3001 蛋白质定量试剂盒(BCA法) Biallelic Variants in EPG5 Gene Are Associated with Parkinson's Disease. 8  Annals of Neurology 
KTD3001 蛋白质定量试剂盒(BCA法) Inhibition of miR-4763-3p expression activates the PI3K/mTOR/Bcl2 autophagy signaling pathway to ameliorate cognitive decline. 8 International Journal of Biological Sciences
KTD3001 蛋白质定量试剂盒(BCA法) S-methylmethionine ameliorates renal injury in diabetic mice by modulating macrophage inflammaging via ERK/NF-κb signaling pathway 5 Biomedicine & Pharmacotherapy
意见反馈
在线咨询
扫码关注

微信公众号

返回顶部